Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Serum Proteomic Study of Women With Obsessive-Compulsive Disorder, Washing Subtype.
Basic Clin Neurosci. 2018 Sep-Oct;9(5):337-346. doi: 10.32598/bcn.9.5.337. Epub 2018 Sep 1.
Basic Clin Neurosci. 2018.
PMID: 30719248
Free PMC article.
Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach.
Zamanian Azodi M, Rezaei Tavirani M, Arefi Oskouie A, Hamdieh M, Derakhshan MK, Ahmadzadeh A, Zayeri F, Nejadi N, Rezaei Tavirani M, Mansouri V, Rostami-Nejad M, Vafaee R.
Zamanian Azodi M, et al. Among authors: derakhshan mk.
Iran J Pharm Res. 2017 Summer;16(3):1264-1271.
Iran J Pharm Res. 2017.
PMID: 29201116
Free PMC article.
Item in Clipboard
Psychometric Evaluation of a Persian Version of Beliefs about Emotions Scale in Community and Clinical Samples.
Ghapanchi A, Abasi I, Rimes KA, Bitarafan M, Zarabi H, Derakhshan FS, Derakhshan MK, Ghanadanzadeh S, Whitley H, Shamsi A.
Ghapanchi A, et al. Among authors: derakhshan mk.
Iran J Psychiatry. 2024 Jan;19(1):89-98. doi: 10.18502/ijps.v19i1.14343.
Iran J Psychiatry. 2024.
PMID: 38420278
Free PMC article.
Item in Clipboard
Psychometric properties of the Persian version of the somatic symptom disorder-B Criteria Scale (SSD-12) in community and clinical samples.
Abasi I, Ghapanchi A, Toussaint A, Bitarafan M, Zarabi H, Derakhshan FS, Banihashem S, Mohammadi N, Ghasemzadeh MR, Derakhshan MK.
Abasi I, et al. Among authors: derakhshan mk.
Gen Hosp Psychiatry. 2022 Sep-Oct;78:1-8. doi: 10.1016/j.genhosppsych.2022.04.010. Epub 2022 Apr 27.
Gen Hosp Psychiatry. 2022.
PMID: 35728363
Item in Clipboard
A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
Salimi S, Fotouhi A, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Mohammadi MR, Noorbala AA, Ahmadi-Abhari SA, Hajiazim M, Abbasi SH, Akhondzadeh S.
Salimi S, et al. Among authors: derakhshan mk.
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):726-32. doi: 10.1016/j.pnpbp.2007.11.021. Epub 2007 Nov 23.
Prog Neuropsychopharmacol Biol Psychiatry. 2008.
PMID: 18096287
Clinical Trial.
Item in Clipboard
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S.
Amiri A, et al. Among authors: derakhshan mk.
Hum Psychopharmacol. 2008 Mar;23(2):79-86. doi: 10.1002/hup.902.
Hum Psychopharmacol. 2008.
PMID: 17972359
Clinical Trial.
Item in Clipboard
Prospective evaluation of technetium-99m ECD SPET in mild traumatic brain injury for the prediction of sustained neuropsychological sequels.
Mehrazin M, Nezameddini-Kachooei SA, Fallahi B, Derakhshan MK, Beiki D, Ghodsi SM, Assadi M, Pooyafard F, Eftekhari M.
Mehrazin M, et al. Among authors: derakhshan mk.
Hell J Nucl Med. 2011 Sep-Dec;14(3):243-50.
Hell J Nucl Med. 2011.
PMID: 22087443
Item in Clipboard
Cite
Cite